Hereditary coproporphyria: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
CSV import
 
(2 intermediate revisions by the same user not shown)
Line 1: Line 1:
'''Hereditary coproporphyria''' ('''HCP''') is a disorder that affects the production of [[heme]], a vital substance for the body. Heme is a component of [[hemoglobin]], the molecule that carries oxygen in the blood.
{{SI}}
 
{{Infobox medical condition
== Causes ==
| name            = Hereditary coproporphyria
 
| image          = [[File:Coproporphyrinogen_III.svg|200px]]
HCP is caused by mutations in the [[CPOX]] gene. This gene provides instructions for making an enzyme called coproporphyrinogen oxidase, which is essential for the production of heme. Mutations in the CPOX gene reduce the activity of this enzyme, disrupting heme production and leading to the accumulation of porphyrins or porphyrin precursors.
| caption        = Structure of coproporphyrinogen III
 
| synonyms        = HCP
== Symptoms ==
| pronounce      =
 
| specialty      = [[Hematology]], [[Genetics]]
The symptoms of HCP can vary widely among affected individuals. Some people with HCP never experience symptoms. When symptoms occur, they can include abdominal pain, vomiting, and constipation. Other symptoms can include muscle pain, tingling or numbness in the hands or feet, and sensitivity to sunlight.
| symptoms        = [[Abdominal pain]], [[neuropathy]], [[psychiatric symptoms]]
 
| onset          = Typically in [[adulthood]]
== Diagnosis ==
| duration        = Episodic
 
| causes          = [[Genetic mutation]] in the [[CPOX]] gene
HCP is diagnosed through a series of tests that measure the levels of porphyrins and porphyrin precursors in the body. These tests can include urine tests, blood tests, and stool tests. Genetic testing can also be used to identify mutations in the CPOX gene.
| risks          = [[Hormonal changes]], [[alcohol]], certain [[medications]]
 
| diagnosis      = [[Urine test]], [[genetic testing]]
== Treatment ==
| differential    = [[Acute intermittent porphyria]], [[variegate porphyria]]
 
| treatment      = [[Glucose]] and [[heme]] infusions, avoidance of triggers
There is currently no cure for HCP. Treatment is focused on managing symptoms and preventing complications. This can include avoiding triggers that can cause symptoms, such as certain medications, alcohol, and fasting. In some cases, medications may be used to reduce the levels of porphyrins and porphyrin precursors in the body.
| prognosis      = Variable, can be managed with treatment
 
| frequency      = Rare
== See also ==
| deaths          = Rare, if untreated
 
}}
'''Hereditary coproporphyria''' (HCP) is a type of [[porphyria]], which is a group of rare metabolic disorders resulting from a deficiency in one of the enzymes involved in the [[heme]] biosynthesis pathway. HCP is characterized by a deficiency of the enzyme coproporphyrinogen oxidase, leading to the accumulation of porphyrins and their precursors, which can cause a variety of symptoms.
==Pathophysiology==
Hereditary coproporphyria is caused by mutations in the [[CPOX gene]], which encodes the enzyme coproporphyrinogen oxidase. This enzyme is responsible for the conversion of coproporphyrinogen III to protoporphyrinogen IX in the heme biosynthesis pathway. A deficiency in this enzyme leads to the accumulation of coproporphyrinogen III and other porphyrin precursors, which can cause neurovisceral attacks and cutaneous symptoms.
==Clinical Presentation==
The clinical manifestations of hereditary coproporphyria can vary widely among individuals. Common symptoms include:
* Abdominal pain
* Neurological disturbances such as seizures, neuropathy, and psychiatric symptoms
* Photosensitivity leading to skin lesions
The symptoms are often triggered by factors such as certain medications, alcohol, fasting, and hormonal changes.
==Diagnosis==
Diagnosis of hereditary coproporphyria is based on clinical symptoms, biochemical tests, and genetic testing. Biochemical tests typically show elevated levels of coproporphyrin in the urine and feces. Genetic testing can confirm mutations in the CPOX gene.
==Management==
Management of hereditary coproporphyria involves avoiding triggers, managing symptoms, and in some cases, administering heme preparations to reduce the production of porphyrin precursors. Patients are advised to avoid drugs and other factors that can precipitate attacks.
==Prognosis==
The prognosis for individuals with hereditary coproporphyria varies. With proper management and avoidance of triggers, many individuals can lead relatively normal lives. However, severe attacks can be life-threatening and require prompt medical attention.
==See also==
* [[Porphyria]]
* [[Porphyria]]
* [[Heme]]
* [[Heme]]
* [[Hemoglobin]]
* [[CPOX gene]]
* [[CPOX]]
* [[Photosensitivity]]
 
[[Category:Porphyrias]]
== References ==
 
<references />
 
[[Category:Genetic disorders]]
[[Category:Metabolic disorders]]
[[Category:Rare diseases]]
 
{{stub}}
{{dictionary-stub1}}
{{No image}}

Latest revision as of 04:42, 7 April 2025

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD medical weight loss NYC and sleep center NYC

Hereditary coproporphyria
Synonyms HCP
Pronounce
Specialty Hematology, Genetics
Symptoms Abdominal pain, neuropathy, psychiatric symptoms
Complications N/A
Onset Typically in adulthood
Duration Episodic
Types N/A
Causes Genetic mutation in the CPOX gene
Risks Hormonal changes, alcohol, certain medications
Diagnosis Urine test, genetic testing
Differential diagnosis Acute intermittent porphyria, variegate porphyria
Prevention N/A
Treatment Glucose and heme infusions, avoidance of triggers
Medication N/A
Prognosis Variable, can be managed with treatment
Frequency Rare
Deaths Rare, if untreated


Hereditary coproporphyria (HCP) is a type of porphyria, which is a group of rare metabolic disorders resulting from a deficiency in one of the enzymes involved in the heme biosynthesis pathway. HCP is characterized by a deficiency of the enzyme coproporphyrinogen oxidase, leading to the accumulation of porphyrins and their precursors, which can cause a variety of symptoms.

Pathophysiology[edit]

Hereditary coproporphyria is caused by mutations in the CPOX gene, which encodes the enzyme coproporphyrinogen oxidase. This enzyme is responsible for the conversion of coproporphyrinogen III to protoporphyrinogen IX in the heme biosynthesis pathway. A deficiency in this enzyme leads to the accumulation of coproporphyrinogen III and other porphyrin precursors, which can cause neurovisceral attacks and cutaneous symptoms.

Clinical Presentation[edit]

The clinical manifestations of hereditary coproporphyria can vary widely among individuals. Common symptoms include:

  • Abdominal pain
  • Neurological disturbances such as seizures, neuropathy, and psychiatric symptoms
  • Photosensitivity leading to skin lesions

The symptoms are often triggered by factors such as certain medications, alcohol, fasting, and hormonal changes.

Diagnosis[edit]

Diagnosis of hereditary coproporphyria is based on clinical symptoms, biochemical tests, and genetic testing. Biochemical tests typically show elevated levels of coproporphyrin in the urine and feces. Genetic testing can confirm mutations in the CPOX gene.

Management[edit]

Management of hereditary coproporphyria involves avoiding triggers, managing symptoms, and in some cases, administering heme preparations to reduce the production of porphyrin precursors. Patients are advised to avoid drugs and other factors that can precipitate attacks.

Prognosis[edit]

The prognosis for individuals with hereditary coproporphyria varies. With proper management and avoidance of triggers, many individuals can lead relatively normal lives. However, severe attacks can be life-threatening and require prompt medical attention.

See also[edit]